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Summary 
Chondroitin sulfate is an important and major component of articular cartilage, where it occurs as part of the large 
proteoglyean, aggrecan. In the early stages of joint disease, both in animal models and in man, there are changes in 
chondroitin sulfate that affect the chain length and the pattern of sulfation. These changes can be detected by 
monoelonal ntibodies and appear to reflect part of the cellular esponse by the chondrocytes to damage to the articular 
cartilage matrix. The specificity of the changes how that the biosynthesis ofchondroitin sulfate is under tight cellular 
control in ehondrocytes and suggests that selected patterns of sulphation within chains are expressed tosuit different 
biological functions. 
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CHONDROITIN sulfate is an important component of 
most vertebrate tissues. It is present predomi- 
nantly in the extracellular matrix surrounding 
cells and is most abundant in those tissues with a 
large extracellular matrix such as those that form 
the connective tissues of the body, cartilage, skin, 
blood vessels and also bone, ligaments and 
tendons. These tissues also contain large amounts 
of fibrillar proteins, mainly collagen, and their 
properties are determined by the content and 
orientation of the fibrillar collagen and the 
content of glycosaminoglycans such as chondroitin 
sulfate. Where the collagen has a single predomi- 
nant orientation, such as in ligaments and 
tendons, the tissues are tensile and the chondroitin 
sulfate content is quite low, but where there is no 
predominant orientation of the collagen, such as in 
skin, there is a high content of chondroitin sulfate 
and the tissue stretches in tension, but is resilient 
and resists compression. 
How does chondroitin sulfate contribute to the 
functions of these tissue? Chondroitin sulfate is a 
sulfated glycosaminoglycan d is composed of a 
long unbranched polysaccharide chain with a 
repeating disaccharide structure of N-acetylgalac- 
tosamine and glucuronic acid [1]. The chains are 
long and vary in length from 10 to 40 kDa. Most of 
the N-acetylgalactosamine residues are sulfated 
and this varies with tissue source, but is 
predominantly in the 4- or 6-position, with a few 
non-sulfated residues and occasional di-sulfated 
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residues. Chondroitin sulfate is thus a polyanion 
and some of its properties are because it is so 
strongly charged and thus draws water into tissues 
and hydrates them. 
Chondroitin sulfate chains are synthesized by 
cells eovalently attached to proteins, which are 
secreted into the extracellular matrix as proteogly- 
cans. Each chain is attached to the proteoglycan 
by a trisaccharide linkage (CS chain-gal-gal-xyl- 
serine). The chains are synthesized on intracellu- 
lar pathways common to other secreted 
glycoproteins and they are assembled on the 
protein as it passes through the vesicular 
compartments of the medial/trans Golgi, immedi- 
ately prior to secretion. Several families of 
proteoglyeans bearing chondroitin sulfate chains 
have been characterized. These include two of the 
most prominent families of proteoglycans found in 
the extracellular matrix of connective tissues, the 
aggrecan family and the leucine-rich repeat family 
[2]. The aggrecan family are high molecular weight 
(> 500kDa) and aggregate extracellularly by 
binding to hyaluronan. The leucine-rich repeat 
family are of smaller size ( < 200 kDa) and contain 
two members, decorin and biglycan, that contain 
chondroitin sulfate/dermatan sulfate chains. Of 
these, decorin binds to collagen fibrils, whereas 
biglycan has a more pericellular distribution, but 
the full range of their tissue functions have yet to 
be determined (Fig. 1). 
Articular cartilage is a very specialized tissue 
with a particularly large expanded extracellular 
matrix with more than 98% of its volume matrix 
and less than 2% cells. It is the structure and 
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FIG. 1. Chondroitin sulfate structure. 
integrity of the matrix that is essential to the 
tissues load-bearing properties [3]. The physical 
properties of the tissue can be understood largely 
in terms of the contribution made by fibrillar 
collagen and nonfibrillar proteoglycans. The 
collagen network is of fine fibers which have no 
preferred orientation in the mid zone of the 
cartilage and provides an essential framework 
that gives shape and form to the tissue. The 
structure of collagen gives it impressive tensile 
properties and this is utilized in cartilage in a 
special way to produce a tissue that is not only 
strong in tension but also resistant to com- 
pression by filling the interfibrillar matrix with a 
very high content of chondroitin sulfate-rich 
proteoglycan, primarily aggrecan. The aggrecan 
at high concentration draws water into the tissue 
as it creates a large osmotic swelling pressure, 
which swells and expands the matrix. This places 
the collagen network under tension, and a 
balance is achieved when tension in the collagen 
network prevents further entry of water. At this 
equilibrium, with the tissue swollen with water, 
it has good compressive resilience. Another 
feature of the composite collagen-aggrecan or- 
ganization is also important, as aggrecan is not 
only largely immobilized within the matrix, but it 
also offers great resistance to any fluid flow and 
redistribution of water. The tissue thus behaves 
largely as a stiff elastic polymer to sudden impact 
loading, but shows some slow inelastic defor- 
mation with sustained loads. However, removal of 
all loads leads to a redistribution of water and a 
return to the pre-loading equilibrium position. 
The articular cartilage thus forms a tough but 
compliant load-bearing surface, and these charac- 
teristics depend on the integrity of the collagen 
network and the retention within it of a high 
concentration of aggrecan rich in chondroitin 
sulfate. 
In degenerative joint diseases, such as osteoar- 
thritis, there is damage and loss of the articular 
cartilage. A key stage in the degenerative process is 
the loss of proteoglycan from the cartilage and the 
exposure of its collagen network to mechanical 
disruption. However, the results from studies of 
experimental osteoarthritis suggest hat early in 
the process, before there is any fibrillation, there is 
a hypermetabolic repair response in articular 
cartilage with increased synthesis of matrix 
components and increased matrix turnover [4]. The 
increased synthesis of aggrecan in cartilage is 
accompanied by interesting changes in the chon- 
droitin sulfate, which shows a longer chain length 
and the chains contain more epitopes recognized by 
specific antibodies [5]. Although chondroitin chains 
are typically very poorly antigenic it has been 
possible to produce monoclonal antibodies that 
recognize some specific sequences within the 
chains. These appear to be infrequently found in 
normal healthy tissue, but their expression 
increases in cartilage during the early hyperme- 
tabolic response in experimental OA. This change 
has been observed in several different experimental 
animal systems and an increase in chondroitin 
sulfate epitopes has also been observed on the 
aggrecan fragments in the joint fluid of some 
patients following major joint trauma, which 
frequently results in the joint developing OA in 
later life [6]. 
The biological reason for these changes in 
chondroitin sulfate in cartilage in early OA is not 
yet clear, but it may suggest that there are specific 
biological functions of selected sequences within 
chondroitin sulfate chains that may be important 
to the processes of tissue repair. There is thus 
considerable interest in gaining a better under- 
standing of what controls the sulphation pattern 
within chondroitin sulfate chains [7] and how it 
changes in response to the effects of cellular 
mediators and biomechanical forces acting on the 
cells in which the chains are synthesized. 
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